The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor

Pituitary Adenomas Clinical Trial

Official title:

The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01377701
• Other study ID #: KY2010-259
• Status: Recruiting
• Phase: N/A
• First received: June 20, 2011
• Last updated: June 20, 2011
• Start date: June 2011
• Est. completion date: December 2012

Study information

• Verified date: June 2011
• Source: Huashan Hospital
• Contact: Yao Zhao, M.D.
• Phone: 86-13916872553
• Email: zhaoyaohs[@]vip.sina.com
• Is FDA regulated: No
• Health authority: China: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

Pituitary adenomas can cause compression of optic nerves and chiasm, which will lead to damage of vision. This study aims to evaluate the predictive factors for recovery of vision in patients with pituitary adenomas following trans-sphenoidal surgery.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 150
• Est. completion date: December 2012
• Est. primary completion date: December 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• >18 years old

• patients with pituitary adenomas, loss of visual field

• patients receive trans-sphenoidal surgery

Exclusion Criteria:

• visual damage caused by other diseases

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Pituitary Adenomas
• Pituitary Diseases
• Pituitary Neoplasms

Locations

Country	Name	City	State
China	Huashan Hospital	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
Huashan Hospital

Country where clinical trial is conducted

China,